TDOC 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

03
가격 $5.52
시가총액 (MRQ) $1.00B
P/E (TTM) -5.6
EPS (TTM) $-0.99
매출 (TTM) $2.49B
ROE (TTM) -13.0%
52주 범위 $4–$10

TDOC 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

04
범위
막대

막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.

Teladoc Health, Inc. Common Stock 정보 위키백과 회사 개요

05 · wikidata

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

섹터Health Care 산업Health Care 직원4,648 국가US

10년 성과 매출, 순이익, 마진 및 EPS 추세

06
매출$2.53B
2016-12-31 → 2025-12-31
EPS$-1.14
2019-12-31 → 2025-12-31
잉여현금흐름$285M
2017-12-31 → 2025-12-31
순이익률-7.1%
2017-12-31 → 2025-12-31
가치 평가 및 비율 07–12

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표 5년 추세 TDOC 5년 평균 동종업계 중앙값 결론
P/E (TTM) -5.65년 평균 ≈-11.5 ≈-11.5 · ·
P/S (TTM) 0.45년 평균 ≈2.3 ≈2.3 2.5 저평가
P/B (MRQ) 0.85년 평균 ≈1.2 ≈1.2 2.9 저평가
주가 / FCF (TTM) 4.05년 평균 ≈24.5 ≈24.5 · ·
주가 / 현금 흐름 (TTM) 3.85년 평균 ≈23.2 ≈23.2 12.7 저평가
주가 / 유형 장부 가치 (MRQ) 7.5 · · ·

동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.

가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

14
평균 서프라이즈 0.53%
다음 실적 10월 27, 2026
기간보고서EPS ActualEPS 예상서프라이즈
2026년 6월 30일 7월 27, 2026 $-0.21 $-0.25 17.6%
2026년 3월 31일 $-0.36 $-0.32 -12.6%
2025년 12월 31일 $-0.14 $-0.19 26.9%
2025년 9월 30일 $-0.28 $-0.27 -3.2%
2025년 6월 30일 $-0.19 $-0.27 28.7%
2025년 3월 31일 $-0.53 $-0.34 -54.2%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

15
손익계산서 18
지표 추세 202520242023202220212020201920182017201620152014
Revenue $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M$44M
Cost of Revenue ···$744M$650M$391M$184M$129M$62M$32M$21M$10M
Gross Profit ·······$289M$172M$91M$56M$34M
R&D Expense $278M$307M$349M$334M$312M$165M$65M$54M$34M$22M$14M$8M
SG&A Expense $432M$435M$465M$450M$438M$507M$164M$117M$80M$49M$43M$18M
Operating Expenses $2.79B$3.59B$2.85B$16.06B$2.30B$1.60B$634M$489M$309M···
Operating Income $-263M$-1.02B$-249M$-13.65B$-266M$-506M$-80M$-71M$-75M$-63M$-56M$-15M
Interest Expense ·$24M$22M$22M$81M·······
Interest Income $37M$57M$47M$13M$776.0K·······
Other Non-op $10M$-6M$4M$-859.0K$5M$-545.0K$342.0K·····
Pretax Income $-236M$-994M$-220M$-13.66B$-385M$-576M$-109M$-97M$-107M$-74M$-58M$-17M
Income Tax $-35M$8M$760.0K$-4M$44M$-91M$-11M$118.0K$-225.0K$510.0K$36.0K$388.0K
Net Income $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M$-17M
EPS (Basic) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
EPS (Diluted) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Shares (Basic) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
Shares (Diluted) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
EBITDA $-263M$-1.02B$-249M$-13.40B$-61M$-437M$-80M$-35M$-56M·$-51M·
대차대조표 28
지표 추세 202520242023202220212020201920182017201620152014
Cash & Equivalents $781M$1.30B$1.12B$918M$893M$733M$514M$424M$43M$50M$55M$46M
Short-term Investments ·······$55M$79M$16M$82M·
Receivables $193M$214M$217M$211M$169M$169M$57M$44M$27M$14M$12M$7M
Inventory $38M$38M$30M$56M$73M$56M$0·····
Prepaid Expense $107M$113M$118M$130M$87M$47M$14M$11M$7M$3M$2M$966.0K
Other Current Assets $2M$3M$7M$12M$6M·······
Current Assets $1.12B$1.66B$1.49B$1.32B$1.23B$1.06B$588M$533M$156M$83M$152M$54M
PP&E (Net) $27M$29M$32M$30M$27M$29M$10M$10M$9M$7M$6M$1M
PP&E (Gross) $112M$101M$92M$77M$61M$51M$26M$22M$17M$12M$8M$2M
Accum. Depreciation $85M$71M$60M$48M$34M$22M$16M$12M$8M$4M$2M$1M
Goodwill $283M$283M$1.07B$1.07B$14.50B$14.58B$746M$737M$499M$188M$56M$28M
Intangibles $1.30B$1.43B$1.68B$1.84B$1.91B$2.02B$225M$247M$160M$25M$15M$8M
Other Non-current Assets $106M$81M$80M$49M$21M$18M$7M$1M$858.0K$415.0K$293.0K$296.0K
Total Assets $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Accounts Payable $48M$33M$44M$48M$47M$46M$9M$8M$4M$2M$2M$2M
Current Liabilities $405M$942M$421M$400M$331M$333M$90M$62M$40M$21M$18M$10M
Capital Leases $34M$32M$43M$38M$42M$43M$25M$0····
Deferred Tax $29M$50M$49M$51M$76M$102M$22M$32M$13M$2M$1M$482.0K
Other Non-current Liabilities $643.0K$720.0K$1M$2M$1M$2M$9M$6M$5M$8M$7M$3M
Total Liabilities $1.47B$2.03B$2.07B·········
Long-term Debt ·········$44M$26M$26M
Total Debt ····$0$43M····$26M·
Common Stock $178.0K$173.0K$167.0K$163.0K$160.0K$150.0K$73.0K$70.0K$61.0K$46.0K$38.0K$2.0K
Retained Earnings $-16.43B$-16.23B$-15.23B$-15.01B$-1.42B$-993M$-508M$-409M$-312M$-205M$-131M$-72M
AOCI $-35M$-38M$-37M$-43M$-6M$19M$-17M$-13M$4M$-1.0K$-42.0K·
Stockholders' Equity $1.39B$1.49B$2.33B$2.31B$16.05B$15.88B$1.01B$1.01B$559M$231M$179M$-68M
Liabilities + Equity $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Shares Outstanding 178,315,400173,405,016166,658,253162,840,360160,469,325150,281,09972,761,94170,516,24961,534,10146,201,56338,524,9222,037,999
현금 흐름 18
지표 추세 202520242023202220212020201920182017201620152014
D&A ···$256M$204M$69M$39M$36M$19M$8M$5M$2M
Stock-based Comp $80M$146M$202M$218M$303M$476M$67M$44M$31M$8M$3M$533.0K
Deferred Tax $-41M$-1M$-2M$-8M$41M$-91M$-11M$-2M$-591.0K$510.0K$36.0K$388.0K
Amort. of Intangibles $351M$363M$326M$245M$195M$65M$36M$32M$15M$6M$4M$2M
Restructuring $19M$20M$17M$7M···$1M····
Other Non-cash ···$13.38B$75M$-23M·$15M$23M·$3M·
Operating Cash Flow $294M$294M$350M$189M$194M$-54M$30M$-5M$-34M$-52M$-47M$-11M
CapEx $9M$11M$11M$16M$9M$4M$4M$4M$3M$2M$6M$1M
Investing Cash Flow $-266M$-124M$-156M$-168M$-73M$-591M$25M$-257M$-448M$26M$-108M·
Debt Issued ·······$10.0K$167M$35M$7M$20M
Net Debt Issued ······$0$10.0K$-60M·$468.0K·
Stock Issued ·····$0$0$331M$259M$250.0K$163M·
Stock Repurchased ···········$368.0K
Net Stock Activity ·····$0$0$331M$259M···
Financing Cash Flow $-552M$8M$11M$6M$41M$859M$35M$646M$475M$21M$164M·
Taxes Paid $9M$9M$7M$3M$4M$1M$1M$441.0K$137.0K···
Free Cash Flow $285M$283M$339M$173M$185M$-58M$26M$-9M$-37M·$-53M·
Levered FCF ·$259M$316M·········
수익성 8
지표 추세 202520242023202220212020201920182017201620152014
Gross Margin ·······69.2%73.6%·72.8%·
Operating Margin -10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%·-72.1%·
Net Margin -7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%·-75.0%·
Pretax Margin -9.3%-38.7%-8.4%-567.7%-18.9%-52.6%-19.8%-23.2%-45.9%·-74.9%·
EBITDA Margin -10.4%-39.7%-9.6%-556.6%-3.0%-39.9%-14.5%-8.4%-24.1%·-65.8%·
ROA -6.3%-25.3%-5.0%-123.7%-2.4%-5.0%-6.3%-8.2%-18.9%·-36.1%·
ROE -14.3%-66.8%-9.5%-326.8%-2.7%-5.4%-9.8%-9.5%-27.0%·-104.5%·
ROIC -16.1%-69.0%-10.7%-591.5%-1.8%-2.7%-7.2%-7.0%-13.5%·-27.2%·
유동성 및 지급능력 5
지표 추세 202520242023202220212020201920182017201620152014
Current Ratio 2.81.83.53.33.73.26.58.53.9·8.4·
Quick Ratio 2.41.63.22.83.22.76.38.43.7·8.3·
Debt / Equity ····0.00.0····0.1·
LT Debt / Equity ··········0.1·
Interest Coverage ·-42.9-11.2·········
효율성 3
지표 추세 202520242023202220212020201920182017201620152014
Asset Turnover 0.80.60.60.20.10.10.40.40.4·0.5·
Inventory Turnover ···11.510.013.8······
Receivables Turnover 12.411.912.212.712.09.711.011.811.4·8.2·
주당 5
지표 추세 202520242023202220212020201920182017201620152014
Book Value / Share $7.77$8.60$13.96$14.17$99.99$105.69$13.94$14.37$9.08·$4.63·
Revenue / Share $14.36$15.07$15.81$14.91$12.95·······
Cash Flow / Share $1.67$1.72$2.13$1.17$1.24·······
Cash / Share $4.38$7.49$6.74$5.64$5.57$4.88$7.07$6.01$0.70·$1.43·
EPS (TTM) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
성장률 3
지표 추세 202520242023202220212020201920182017201620152014
Revenue YoY -1.5%-1.3%8.1%18.4%85.8%·······
Revenue CAGR 3Y 1.7%8.1%33.5%·········
Revenue CAGR 5Y 18.3%···········
가치 평가 (TTM) 13
지표 추세 202520242023202220212020201920182017201620152014
Revenue TTM $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M·
Net Income TTM $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M·
Market Cap $1.25B$1.58B$3.59B$3.85B$14.73B$30.05B$6.09B$3.50B$2.14B·$692M·
Enterprise Value ····$13.84B$29.36B····$581M·
P/E -6.1-1.5-16.1-0.3-33.6-37.3-60.7·····
P/S 0.50.61.41.67.227.511.08.49.2·8.9·
P/B 0.91.11.51.70.91.96.03.53.8·3.9·
P / Cash Flow 4.25.410.320.376.0-561.6203.9-719.2-62.3·-14.7·
P / FCF 4.45.610.622.379.4-522.3231.1-394.0-57.8·-12.9·
EV / EBITDA ····-225.4-67.2····-11.4·
EV / FCF ····74.6-510.3····-10.9·
EV / Revenue ····6.826.8····7.5·
Earnings Yield -16.3%-64.6%-6.2%-357.7%-3.0%-2.7%-1.7%·····

최신 기간은 왼쪽에 · null 값은 ·로 표시

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

16
지표 2025-12-312024-12-312023-12-312022-12-312021-12-31
매출 $2.53B $2.57B $2.60B $2.41B $2.03B
영업이익률 % -10.4% -39.7% -9.6% -567.3% -13.1%
순이익 $-200M $-1.00B $-220M $-13.66B $-429M
희석 EPS $-1.14 $-5.87 $-1.34 $-84.60 $-2.73

기관 투자자 (13F) 392개의 제출자 · $1.5B 전체 · 기준일 2026년 9월 30일

17

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

보유자 392
보유 가치 $1.5B
신규 포지션 65
청산 포지션 34
기관 활동 — Q2 2026 대 이전 분기
신규 포지션 청산 포지션 증가함 감소 순주식 변동
65 (-2 이전 분기 대비) 34 (-38 이전 분기 대비) 111 (-8 이전 분기 대비) 94 (+9 이전 분기 대비) +11.8M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관 가치 주식 % 추적된 13F 중 유형
VANGUARD GROUP INC $150,385,949 21,483,707 9.91% 주식
BlackRock, Inc. $137,572,176 16,223,134 9.07% 주식
VANGUARD PORTFOLIO MANAGEMENT LLC $107,573,820 12,685,592 7.09% 주식
Point72 Asset Management, L.P. $69,874,581 8,239,927 4.61% 주식
RENAISSANCE TECHNOLOGIES LLC $68,457,700 8,072,842 4.51% 주식
Voss Capital, LP $68,235,838 8,046,679 4.50% 주식
VANGUARD CAPITAL MANAGEMENT LLC $67,458,671 7,955,032 4.45% 주식
DIMENSIONAL FUND ADVISORS LP $62,515,646 7,371,699 4.12% 주식
STATE STREET CORP $42,080,999 4,962,382 2.77% 주식
AMERICAN CENTURY COMPANIES INC $41,505,394 4,894,504 2.74% 주식
Allianz Asset Management GmbH $39,572,734 4,666,596 2.61% 주식
GEODE CAPITAL MANAGEMENT, LLC $39,472,353 4,653,834 2.60% 주식
GOLDMAN SACHS GROUP INC $32,412,969 3,822,284 2.14% 주식
Monaco Asset Management SAM $26,864,462 3,167,979 1.77% 주식
JUPITER ASSET MANAGEMENT LTD $26,370,375 3,109,714 1.74% 주식
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25,976,377 3,063,252 1.71% 주식
Quantinno Capital Management LP $23,904,416 2,818,917 1.58% 주식
FEDERATED HERMES, INC. $18,037,027 2,127,008 1.19% 주식
UBS Group AG $17,401,181 2,052,026 1.15% 주식
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17,299,632 2,040,051 1.14% 주식
AMERIPRISE FINANCIAL INC $16,998,584 2,004,550 1.12% 주식
Pale Fire Capital SE $16,737,502 1,973,762 1.10% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16,435,088 1,938,100 1.08% 콜 옵션
NORTHERN TRUST CORP $15,055,374 1,775,398 0.99% 주식
AQR CAPITAL MANAGEMENT LLC $14,855,924 1,751,878 0.98% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11,710,032 1,380,900 0.77% 풋 옵션
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11,348,708 1,338,291 0.75% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11,229,479 1,324,231 0.74% 주식
MORGAN STANLEY $11,055,129 1,303,670 0.73% 주식
VANGUARD FIDUCIARY TRUST CO $10,120,074 1,193,405 0.67% 주식
BNP PARIBAS FINANCIAL MARKETS $9,796,800 1,155,283 0.65% 주식
FRANKLIN RESOURCES INC $9,710,439 1,145,099 0.64% 주식
Allspring Global Investments Holdings, LLC $9,024,853 991,742 0.59% 주식
Freestone Grove Partners LP $7,338,160 865,349 0.48% 주식
Man Group plc $6,880,545 811,385 0.45% 주식
PRINCIPAL FINANCIAL GROUP INC $6,827,859 805,172 0.45% 주식
CITADEL ADVISORS LLC $6,795,024 801,300 0.45% 풋 옵션
Union Square Park Capital Management, LLC $6,784,000 800,000 0.45% 주식
CITADEL ADVISORS LLC $6,532,093 770,294 0.43% 주식
FMR LLC $6,449,076 760,504 0.43% 주식
TCW GROUP INC $6,248,039 736,797 0.41% 주식
Voss Capital, LP $5,936,000 700,000 0.39% 콜 옵션
Empowered Funds, LLC $5,764,619 679,790 0.38% 주식
Bank of New York Mellon Corp $5,535,043 652,717 0.36% 주식
D. E. Shaw & Co., Inc. $5,420,493 639,209 0.36% 주식
PEAK6 LLC $5,227,920 616,500 0.34% 콜 옵션
CITADEL ADVISORS LLC $5,114,288 603,100 0.34% 콜 옵션
Squarepoint Ops LLC $5,089,696 600,200 0.34% 콜 옵션
JANE STREET GROUP, LLC $5,088,848 600,100 0.34% 풋 옵션
JPMORGAN CHASE & CO $4,283,818 484,856 0.28% 주식

전체 392 기관 투자자 보기 →

행동주의자 및 5% 이상 소유자 2 보유

18

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자 제출됨 지분 상태 목적 제출
Kinnevik AB (publ), Invik S.A. ×3 제출 서류 2021년 4월 15일 · 최초 제출 · SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 제출 서류 2021년 3월 16일 · 최초 제출 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

회사 내부자 56 명의 내부자 · 29 임원 · 24 이사

19
내부자 역할 마지막 활동 보유 주식 수 매수 12개월 매도 12개월 순매수/매도 12개월
Charles Divita III CHIEF EXECUTIVE OFFICER 2026년 9월 10일 M 465,535 0 7 $-1,035,229
Laizer Kornwasser Advisor to the CEO 2024년 8월 1일 M 99,929 0 0 $0
Jason N Gorevic CHIEF EXECUTIVE OFFICER 2024년 3월 19일 A 653,073 0 0 $0
Michael F Grasher Chief Financial Officer 2026년 9월 1일 A · 0 0 $0
Mala Murthy CHIEF FINANCIAL OFFICER 2025년 8월 29일 M 142,385 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO 2018년 12월 13일 M 10,000 0 0 $0
Carlos Nueno President, International 2026년 9월 1일 M 64,744 0 4 $-218,769
Fernando M. Rodrigues President of BetterHelp 2026년 9월 1일 M 0 0 8 $-469,637
Kelly Bliss President, U.S. Group Health 2026년 9월 1일 M 92,832 0 7 $-343,192
Peter A Mcclennen President 2019년 7월 15일 M 0 0 0 $0
Michael Willem Waters CHIEF OPERATING OFFICER 2024년 8월 30일 M 78,309 0 0 $0
David William Sides Chief Operating Officer 2021년 7월 29일 M 11,031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer 2026년 9월 1일 M 12,865 0 6 $-25,521
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 2026년 9월 1일 M 117,616 0 4 $-289,541
Vidya Raman-Tangella CHIEF MEDICAL OFFICER 2024년 9월 4일 S 33,665 0 0 $0
Andrew Turitz EVP, CORPORATE DEVELOPMENT 2024년 9월 4일 S 20,773 0 0 $0
James L. Cave INTERIM CAO 2024년 8월 30일 M 13,808 0 0 $0
Nikolaos P. Nanis Chief Technology Officer 2024년 8월 30일 M 75,410 0 0 $0
Arnnon Geshuri CHIEF PEOPLE OFFICER 2024년 8월 30일 M 44,914 0 0 $0
Daniel Trencher CHIEF STRATEGY OFFICER 2024년 8월 30일 M 31,465 0 0 $0
Stephany Verstraete CHIEF MARKETING OFFICER 2024년 8월 30일 M 48,843 0 0 $0
Richard J Napolitano CHIEF ACCOUNTING OFFICER 2024년 3월 19일 A 18,077 0 0 $0
Claus Torp Jensen CHIEF INNOVATION OFFICER 2023년 12월 1일 M 20,703 0 0 $0
Lewis Levy Chief Medical Officer 2020년 10월 1일 M 8,766 0 0 $0
Michelle Bucaria Chief Human Resources Officer 2020년 9월 1일 M 3,232 0 0 $0
Christopher Caridi Chief Accounting Officer 2020년 7월 1일 A · 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO 2020년 4월 16일 M 988 0 0 $0
Michael H. King Chief Sales Officer 2017년 5월 25일 A 61,459 0 0 $0
Peter N. Nieves EVP and CRO 2017년 3월 13일 A · 0 0 $0
Mark V Anquillare 이사 2026년 8월 3일 A · 0 0 $0
Catherine Jacobson 이사 2026년 5월 21일 A 66,853 0 0 $0
Mark Douglas Smith 이사 2026년 5월 21일 A 8,355 0 0 $0
Kenneth H Paulus 이사 2026년 5월 21일 A 10,000 1 0 $69,400
David B Snow JR 이사 2026년 5월 21일 A 113,032 0 0 $0
David L Shedlarz 이사 2026년 5월 21일 A 61,266 0 0 $0
Susan R Salka 이사 2026년 3월 30일 A · 0 0 $0
Michael S Smith 이사 2026년 2월 18일 A · 0 0 $0
Jason Eric Evans 이사 2025년 12월 19일 M 9,145 0 0 $0
Thomas Mckinley 이사 2025년 5월 22일 A 56,544 0 0 $0
Karen L Daniel 이사 2024년 5월 22일 M 36,995 0 0 $0
William H. Frist 이사 2022년 5월 26일 A 12,918 0 0 $0
Christopher Bischoff 이사 2022년 5월 17일 M 7,195 0 0 $0
Hemant Taneja 이사 2021년 4월 19일 S 118,760 0 0 $0
Glen Tullman 이사 2021년 4월 1일 M 275,793 0 0 $0
Helen Darling 이사 2020년 6월 11일 M 918 0 0 $0
Arneek Multani 이사 2019년 5월 30일 A 918 0 0 $0
Brian P Mcandrews 이사 2019년 5월 30일 A 1,965 0 0 $0
Tom Mawhinney 이사 2018년 5월 25일 M 46,203 0 0 $0
Martin R Felsenthal 이사 2016년 8월 8일 A 10,860 0 0 $0
Dana G Mead Jr. 이사 2016년 8월 8일 A 202 0 0 $0
James K Outland 이사 2015년 7월 13일 M 49,986 0 0 $0
CHP III Management, L.L.C. 10% 소유주 2017년 4월 26일 J 2,480,468 0 0 $0
CHP III LP 10% 소유주 2017년 4월 26일 J 2,480,468 0 0 $0
Sandra L Fenwick · 2026년 5월 21일 A 12,070 0 0 $0
Yulun Wang · 2021년 1월 25일 S 219,507 0 0 $0
Michael Goldstein · 2020년 6월 11일 M 0 0 0 $0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

ETF 보유 현황 37 ETF 보유

20

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드 비중 단위 기준일 출처
IHF · iShares Trust 0.16% 347,966 SH 2026년 9월 11일 일간
VTWV · VANGUARD SCOTTSDALE FUNDS 0.10% 159,976 SH 2026년 8월 19일 일간
DFSV · Dimensional ETF Trust 0.08% 1,038,485 NS 2026년 7월 31일 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.05% 1,047,849 SH 2026년 8월 19일 일간
ESML · iShares Trust 0.05% 219,811 SH 2026년 9월 11일 일간
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.05% 47,383 NS 2026년 7월 31일 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.04% 29,737 SH 2026년 8월 19일 일간
RSSL · Global X Funds 0.04% 87,202 NS 2026년 7월 31일 N-PORT
IWM · iShares Trust 0.04% 4,676,471 SH 2026년 9월 11일 일간
VBR · VANGUARD INDEX FUNDS 0.03% 2,631,374 SH 2026년 8월 19일 일간
PNQI · Invesco Exchange-Traded Fund Trust 0.03% 27,091 SH 2026년 10월 2일 일간
DFAT · Dimensional ETF Trust 0.02% 528,876 NS 2026년 7월 31일 N-PORT
VXF · VANGUARD INDEX FUNDS 0.02% 2,084,219 SH 2026년 8월 19일 일간
VB · VANGUARD INDEX FUNDS 0.02% 4,153,113 SH 2026년 8월 19일 일간
VHT · VANGUARD WORLD FUND 0.02% 535,056 SH 2026년 8월 19일 일간
FHLC · FIDELITY COVINGTON TRUST 0.02% 83,458 NS 2026년 7월 31일 N-PORT
DFAS · Dimensional ETF Trust 0.01% 325,784 NS 2026년 7월 31일 N-PORT
DXUV · Dimensional ETF Trust 0.01% 11,242 NS 2026년 7월 31일 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.01% 176,576 SH 2026년 10월 2일 일간
WSML · iShares Trust 0.01% 10,496 SH 2026년 9월 11일 일간
TILT · FlexShares Trust 0.01% 21,330 NS 2026년 7월 31일 N-PORT
DFAC · Dimensional ETF Trust 0.01% 449,072 NS 2026년 7월 31일 N-PORT
DFSU · Dimensional ETF Trust 0.01% 18,459 NS 2026년 7월 31일 N-PORT
DCOR · Dimensional ETF Trust 0.00% 23,195 NS 2026년 7월 31일 N-PORT
DSI · iShares Trust 0.00% 25,114 SH 2026년 9월 10일 일간
DFUS · Dimensional ETF Trust 0.00% 82,328 NS 2026년 7월 31일 N-PORT
DFAU · Dimensional ETF Trust 0.00% 43,186 NS 2026년 7월 31일 N-PORT
ITOT · iShares Trust 0.00% 232,868 SH 2026년 9월 11일 일간
IWV · iShares Trust 0.00% 45,761 SH 2026년 9월 3일 일간
DFUV · Dimensional ETF Trust 0.00% 16,298 NS 2026년 7월 31일 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 5,687,282 SH 2026년 8월 19일 일간
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 15,175 SH 2026년 8월 19일 일간
IWN · iShares Trust · 1,697,159 SH 2026년 9월 11일 일간
SVAL · iShares Trust · 100,159 SH 2026년 9월 3일 일간
ISCB · iShares Trust · 7,717 SH 2026년 9월 11일 일간
ISCV · iShares Trust · 38,629 SH 2026년 9월 11일 일간
SMLF · iShares Trust · 597,716 SH 2026년 9월 11일 일간

TDOC 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

21
평점 · 31 명의 애널리스트 보유
중앙값 목표 $7.50 +35.9%
4 12.9% 적극 매수
7 22.6% 매수
20 64.5% 보유
0 0.0% 매도
0 0.0% 적극 매도

12개월 목표 주가

17 명의 애널리스트 · 2026-10-02

평균 목표 $7.68 +39.1%

지금 현재가 $5.52
저가$5.50 평균$7.68 고가$10.50

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

22

회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
TDOC $1.25B -6.1 -1.5% -7.9% -14.3% ·
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR · -12.7 23.3% -40.4% -29.2% 55.7%
CERT $1.40B -881.0 8.8% -0.38% -0.15% ·
GDRX · 30.1 0.57% 3.8% 4.8% ·
HSTM $682M 37.8 4.3% 6.0% 5.2% ·
PHR · 335.8 14.5% 0.48% 0.73% ·
CTEV $708M -2.5 3.7% -29.4% 265.9% ·
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

최신 뉴스 이 회사 관련 최근 헤드라인

23

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

26

중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

출처: SEC 10-Q 제출 7월 30, 2026